help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 1, 2004
Endocrinology, doi:10.1210/en.2003-1141
A more recent version of this article appeared on July 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/7/3424    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pisarska, M. D.
Right arrow Articles by Hsueh, A. J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pisarska, M. D.
Right arrow Articles by Hsueh, A. J. W.

Submitted on September 2, 2003
Accepted on March 22, 2004

Forkhead L2 Is Expressed in the Ovary and Represses the Promoter Activity of the Steroidogenic Acute Regulatory Gene

Margareta D. Pisarska, Jeehyeon Bae, Cynthia Klein, and Aaron J. W. Hsueh*

Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305-5317 USA

* To whom correspondence should be addressed. E-mail: aaron.hsueh{at}stanford.edu.

Premature ovarian failure in a subgroup of women with Blepharophimosis-Ptosis-Epicanthus Inversus type 1 syndrome has been associated with nonsense mutations in the gene encoding a Forkhead transcription factor, Forkhead L2 (FOXL2). However, the exact function of FOXL2 in the ovary is unclear. We investigated the expression of FOXL2 in the mouse ovary during follicular development and maturation by RT-PCR and in situ hybridization. The FOXL2 mRNA is expressed in ovaries throughout development and adulthood, and is localized to the undifferentiated granulosa cells in small and medium follicles, as well as cumulus cells of preovulatory follicles. FOXL2 belongs to a group of transcription factors capable of interacting with specific DNA sequences in diverse gene promoters. With the presence of multiple putative forkhead DNA consensus sites, the promoter of the human Steroidogenic Acute Regulatory (StAR) gene was used to test for regulation by FOXL2. Co-transfection studies revealed that wild-type FOXL2 represses the activity of the StAR promoter, and the first 95 bp upstream of the transcriptional start site of the StAR gene is sufficient for FOXL2 repression. Electrophoretic mobility shift assays confirmed that FOXL2 interacts directly with this region. Analyses using FOXL2 mutants also demonstrated the importance of the entire alanine/proline-rich carboxyl terminus of FOXL2 for transcriptional repression. Furthermore, these mutations produce a protein with a dominant negative effect that disables the transcriptional repressor activity of wild-type FOXL2. Dominant negative mutations of FOXL2 could increase expression of StAR and other follicle differentiation genes in small and medium follicles to accelerate follicle development, resulting in increased initial recruitment of dormant follicles and thus the premature ovarian failure phenotype.


Key words: Forkhead • Forkhead L2 • FOXL2 • ovarian failure • granulosa cells • transcriptional repressor • Steroidogenic Acute Regulatory Protein (StAR)




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
D. Beysen, L. Moumne, R. Veitia, H. Peters, B. P. Leroy, A. De Paepe, and E. De Baere
Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation
Hum. Mol. Genet., July 1, 2008; 17(13): 2030 - 2038.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Ottolenghi, E. Pelosi, J. Tran, M. Colombino, E. Douglass, T. Nedorezov, A. Cao, A. Forabosco, and D. Schlessinger
Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells
Hum. Mol. Genet., December 1, 2007; 16(23): 2795 - 2804.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
R. A. Veitia
Exploring the Molecular Etiology of Dominant-Negative Mutations
PLANT CELL, December 1, 2007; 19(12): 3843 - 3851.
[Full Text] [PDF]


Home page
J EndocrinolHome page
Z. Liu, F. Wu, B. Jiao, X. Zhang, C. Hu, B. Huang, L. Zhou, X. Huang, Z. Wang, Y. Zhang, et al.
Molecular cloning of doublesex and mab-3-related transcription factor 1, forkhead transcription factor gene 2, and two types of cytochrome P450 aromatase in Southern catfish and their possible roles in sex differentiation
J. Endocrinol., July 1, 2007; 194(1): 223 - 241.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D.-S. Wang, T. Kobayashi, L.-Y. Zhou, B. Paul-Prasanth, S. Ijiri, F. Sakai, K. Okubo, K.-i. Morohashi, and Y. Nagahama
Foxl2 Up-Regulates Aromatase Gene Transcription in a Female-Specific Manner by Binding to the Promoter as Well as Interacting with Ad4 Binding Protein/Steroidogenic Factor 1
Mol. Endocrinol., March 1, 2007; 21(3): 712 - 725.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Batista, D. Vaiman, J. Dausset, M. Fellous, and R. A. Veitia
Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics
PNAS, February 27, 2007; 104(9): 3330 - 3335.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Stocco, C. Telleria, and G. Gibori
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Endocr. Rev., February 1, 2007; 28(1): 117 - 149.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. S. Ellsworth, N. Egashira, J. L. Haller, D. L. Butts, J. Cocquet, C. M. Clay, R. Y. Osamura, and S. A. Camper
FOXL2 in the Pituitary: Molecular, Genetic, and Developmental Analysis
Mol. Endocrinol., November 1, 2006; 20(11): 2796 - 2805.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. Pannetier, S. Fabre, F. Batista, A. Kocer, L. Renault, G. Jolivet, B. Mandon-Pepin, C. Cotinot, R. Veitia, and E. Pailhoux
FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development.
J. Mol. Endocrinol., June 1, 2006; 36(3): 399 - 413.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. F. Clem and B. J. Clark
Association of the mSin3A-Histone Deacetylase 1/2 Corepressor Complex with the Mouse Steroidogenic Acute Regulatory Protein Gene
Mol. Endocrinol., January 1, 2006; 20(1): 100 - 113.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. A. Pangas and A. Rajkovic
Transcriptional regulation of early oogenesis: in search of masters
Hum. Reprod. Update, January 1, 2006; 12(1): 65 - 76.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S. Tang, X. Wang, L. Lin, Y. Sun, Y. Wang, and H. Yu
Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome
Mutagenesis, January 1, 2006; 21(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
K Raile, H Stobbe, R B Trobs, W Kiess, and R Pfaffle
A new heterozygous mutation of the FOXL2 gene is associated with a large ovarian cyst and ovarian dysfunction in an adolescent girl with blepharophimosis/ptosis/epicanthus inversus syndrome
Eur. J. Endocrinol., September 1, 2005; 153(3): 353 - 358.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society